237 related articles for article (PubMed ID: 32330731)
1. Hypergastrinemia Expands Gastric ECL Cells Through CCK2R
Sheng W; Malagola E; Nienhüser H; Zhang Z; Kim W; Zamechek L; Sepulveda A; Hata M; Hayakawa Y; Zhao CM; Chen D; Wang TC
Cell Mol Gastroenterol Hepatol; 2020; 10(2):434-449.e1. PubMed ID: 32330731
[TBL] [Abstract][Full Text] [Related]
2. Functional impairment of the individual rat stomach ECL cell in response to sustained hypergastrinemia.
Kimura K; Chen D; Lindström E; Yamada H; Zhao CM; Håkanson R
Regul Pept; 1997 Oct; 72(2-3):69-77. PubMed ID: 9652979
[TBL] [Abstract][Full Text] [Related]
3. Depletion of enterochromaffin-like cell histamine increases histidine decarboxylase and chromogranin A mRNA levels in rat stomach by a gastrin-independent mechanism.
Andersson K; Lindström E; Chen D; Monstein HJ; Boketoft A; Håkanson R
Scand J Gastroenterol; 1996 Oct; 31(10):959-65. PubMed ID: 8898415
[TBL] [Abstract][Full Text] [Related]
4. Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus.
Lee Y; Urbanska AM; Hayakawa Y; Wang H; Au AS; Luna AM; Chang W; Jin G; Bhagat G; Abrams JA; Friedman RA; Varro A; Wang KK; Boyce M; Rustgi AK; Sepulveda AR; Quante M; Wang TC
Oncotarget; 2017 Jan; 8(1):203-214. PubMed ID: 27448962
[TBL] [Abstract][Full Text] [Related]
5. Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling.
Varro A; Kenny S; Hemers E; McCaig C; Przemeck S; Wang TC; Bodger K; Pritchard DM
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1133-40. PubMed ID: 17218472
[TBL] [Abstract][Full Text] [Related]
6. Octreotide inhibits the enterochromaffin-like cell but not peroxisome proliferator-induced hypergastrinemia.
Bakke I; Sandvik AK; Waldum HL
J Mol Endocrinol; 2000 Aug; 25(1):109-19. PubMed ID: 10915223
[TBL] [Abstract][Full Text] [Related]
7. Altered influence of CCK-B/gastrin receptors on HDC expression in ECL cells after neoplastic transformation.
Kölby L; Wängberg B; Ahlman H; Modlin IM; Theodorsson E; Nilsson O
Regul Pept; 1999 Dec; 85(2-3):115-23. PubMed ID: 10651065
[TBL] [Abstract][Full Text] [Related]
8. The Enterochromaffin-like [ECL] Cell-Central in Gastric Physiology and Pathology.
Waldum HL; Sørdal ØF; Mjønes PG
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108898
[TBL] [Abstract][Full Text] [Related]
9. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
Håkanson R; Ding XQ; Norlén P; Lindström E
Regul Pept; 1999 Mar; 80(1-2):1-12. PubMed ID: 10235629
[TBL] [Abstract][Full Text] [Related]
10. Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa.
Tatsuguchi A; Hoshino S; Kawami N; Gudis K; Nomura T; Shimizu A; Iwakiri K
Pathol Res Pract; 2020 Oct; 216(10):153113. PubMed ID: 32853950
[TBL] [Abstract][Full Text] [Related]
11. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.
Ding XQ; Lindström E; Håkanson R
Br J Pharmacol; 1997 Sep; 122(1):1-6. PubMed ID: 9298521
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats.
Håkanson R; Tielemans Y; Chen D; Andersson K; Mattsson H; Sundler F
Gastroenterology; 1993 Jul; 105(1):15-21. PubMed ID: 8514032
[TBL] [Abstract][Full Text] [Related]
13. Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats.
Ono M; Sato H; Kazumori H; Yuki M; Rumi MA; Ortega-Cava CF; Ishihara Y; Ishihara S; Adachi K; Kinoshita Y
J Lab Clin Med; 2003 Dec; 142(6):364-71. PubMed ID: 14713888
[TBL] [Abstract][Full Text] [Related]
14. Time course of hypertrophic and ultrastructural responses of rat stomach enterochromaffin-like cells to sustained hypergastrinemia.
Chen D; Zhao CM; Nylander AG; Håkanson R
Cell Tissue Res; 1996 Apr; 284(1):55-63. PubMed ID: 8601296
[TBL] [Abstract][Full Text] [Related]
15. Deletion of
Sundaresan S; Kang AJ; Hayes MM; Choi EK; Merchant JL
Gut; 2017 Jun; 66(6):1012-1021. PubMed ID: 26860771
[TBL] [Abstract][Full Text] [Related]
16. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
17. Histidine decarboxylase expression and histamine metabolism in gastric oxyntic mucosa during hypergastrinemia and carcinoid tumor formation.
Kölby L; Wängberg B; Ahlman H; Modlin IM; Granérus G; Theodorsson E; Nilsson O
Endocrinology; 1996 Oct; 137(10):4435-42. PubMed ID: 8828505
[TBL] [Abstract][Full Text] [Related]
18. Histamine metabolism of gastric carcinoids in Mastomys natalensis.
Kölby L; Wängberg B; Ahlman H; Modlin IM; Nilsson O
Yale J Biol Med; 1998; 71(3-4):207-15. PubMed ID: 10461353
[TBL] [Abstract][Full Text] [Related]
19. Rat histidine decarboxylase promoter is regulated by gastrin through a protein kinase C pathway.
Höcker M; Zhang Z; Fenstermacher DA; Tågerud S; Chulak M; Joseph D; Wang TC
Am J Physiol; 1996 Apr; 270(4 Pt 1):G619-33. PubMed ID: 8928792
[TBL] [Abstract][Full Text] [Related]
20. Serum gastrin and gastric enterochromaffin-like cells during estrous cycle, pregnancy and lactation, and in response to estrogen-like agents in rats.
Vigen RA; Chen D; Syversen U; Stunes K; Hakanson R; Zhao CM
J Physiol Pharmacol; 2011 Jun; 62(3):335-40. PubMed ID: 21893694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
